← Leaderboards
Lance Allen Johnson
University Of Kentucky
$7,508,882
Attributed
$8,412,384
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,412,384 · 4
By mechanism
R01$8,412,384 · 4
Top collaborators
- Sarah Cohen5 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Philip W. Landfield$13,634,726
- Jianhua Shao$10,846,515
- Brandon Charles Farmer$99,721
- Ethan Phares Glaser$104,372
- Andrew N Lane$6,700,927
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
- Leon Maing Tai · University Of Illinois At Chicago$5,935,870
Research focus
Alzheimer&AposBrainS DiseaseAstrocytesGenotypeMetabolismAffectLate Onset Alzheimer DiseaseMouse ModelGenetic Risk FactorApolipoprotein ENeuronsIn VivoS Disease RiskCellsMetabolicProtein IsoformsGenesMetabolomicsPreventImpaired CognitionFutureGeneticLink
Grant awards (20)
APOE Allele Switching as a Therapeutic Approach for Alzheimer's Disease$629,419
R01 · FY2025 · AG · contact PI
Assessing the role of APOE in glial lipid droplet metabolism and function$560,263
R01 · FY2025 · AG
APOE Allele Switching as a Therapeutic Approach for Alzheimer's Disease$642,264
R01 · FY2024 · AG · contact PI
Assessing the role of APOE in glial lipid droplet metabolism and function$571,695
R01 · FY2024 · AG
Assessing the role of APOE in glial lipid droplet metabolism and function$67,904
R01 · FY2024 · AG
Assessing the role of APOE in glial lipid droplet metabolism and function$21,572
R01 · FY2024 · AG
APOE Allele Switching as a Therapeutic Approach for Alzheimer's Disease$642,417
R01 · FY2023 · AG · contact PI
Assessing the role of APOE in glial lipid droplet metabolism and function$585,570
R01 · FY2023 · AG
Changing the energy substrate balance: Does APOE2 promote glucose usage to protect from Alzheimer's Disease?$425,811
R01 · FY2023 · AG · contact PI
APOE and the PPP: Glucose Metabolism and Oxidative Stress in Alzheimer's Disease$508,223
R01 · FY2022 · AG · contact PI
Changing the energy substrate balance: Does APOE2 promote glucose usage to protect from Alzheimer's Disease?$436,980
R01 · FY2022 · AG · contact PI
Changing the energy substrate balance: Does APOE2 promote glucose usage to protect from Alzheimer's Disease?$57,466
R01 · FY2022 · AG · contact PI
APOE and the PPP: Glucose Metabolism and Oxidative Stress in Alzheimer's Disease$508,223
R01 · FY2021 · AG · contact PI
Changing the energy substrate balance: Does APOE2 promote glucose usage to protect from Alzheimer's Disease?$436,980
R01 · FY2021 · AG · contact PI
Examining the Effects of the Neuroprotective APOE2 Allele on Peripheral Immunometabolism$38,308
R01 · FY2021 · AG · contact PI
APOE and the PPP: Glucose Metabolism and Oxidative Stress in Alzheimer's Disease$508,223
R01 · FY2020 · AG · contact PI
Changing the energy substrate balance: Does APOE2 promote glucose usage to protect from Alzheimer's Disease?$418,620
R01 · FY2020 · AG · contact PI
APOE and the PPP: Glucose Metabolism and Oxidative Stress in Alzheimer's Disease$482,213
R01 · FY2019 · AG · contact PI
Changing the energy substrate balance: Does APOE2 promote glucose usage to protect from Alzheimer's Disease?$397,200
R01 · FY2019 · AG · contact PI
APOE and the PPP: Glucose Metabolism and Oxidative Stress in Alzheimer's Disease$473,033
R01 · FY2018 · AG · contact PI